Biosynthesis of Novel Silver Nanoparticles Using Eryngium thyrsoideum Boiss Extract and Comparison of their Antidiabetic Activity with Chemical Synthesized Silver Nanoparticles in Diabetic Rats.

In the present study, silver nanoparticles (1) were synthesized by green method using Eryngium campestre Boiss aqueous extract and silver nanoparticles (2) were synthesized with chemical method. The silver nanoparticles (1) and (2) were characterized with FT-IR, UV-Vis, XRD, EDX, SEM, and TEM analyses. The effects of silver nanoparticles (1) and (2) were investigated on glucose, hematology, and blood biochemical parameters in alloxan- induced diabetes type 1 model rats. Diabetic or intact rats received intraperitoneal injection of saline or 2.5 mg/kg of silver nanoparticles (1) and (2) for 14 consecutive days. Hematological parameters and serum concentration of FBS, HbA1C, ALT, AST, GGT, ALP, albumin, creatinine, and urea were determined. Interestingly, silver NPs (1) or (2) did not exert toxic influences on hematological parameters and liver and kidney function in intact rats. Both silver nanoparticles (1) and (2) exert hypoglycemic effects in diabetic rats. They did not alter urea, creatinine, and hematological parameters except white blood cell (WBC) count in diabetic rats. Silver nanoparticles (1) decreased significantly liver enzyme levels including ALT and AST of diabetic rats. However silver nanoparticles (2) could not suppress the increased levels of liver enzymes in diabetic rats. In comparison with silver nanoparticles (2), the silver nanoparticles (1) are more protective than the same dose of silver nanoparticles (2) in the regulation and improving the liver function in diabetic rats. Also, silver nanoparticles (1) may exert protective effects on liver damage of diabetic rats rather than kidney damage.